D
DBV Technologies S.A. (DBVT)
NCM – Real Time Price. Currency in USD
20.00
-0.36 (-1.77%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
20.00
-0.36 (-1.77%)
At close: May 12, 2026, 4:00 PM EDT
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
| Name | Position |
|---|---|
| Alan Kerr | Senior VP & Head of Global Regulatory Affairs |
| Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C. | Chief Operations Officer |
| Dr. Pharis Mohideen M.D. | Chief Medical Officer |
| Mr. Daniel Tassé | CEO & Director |
| Mr. James Briggs | Chief Human Resources Officer |
| Mr. Jonathan Neely | VP & Head of Investor Relations |
| Mr. Kevin Trapp | Chief Commercial Officer |
| Mr. Pascal Wotling | Chief External Manufacturing & Supply Chain Officer |
| Ms. Michele F. Robertson | Chief Legal Officer |
| Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A. | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-05 | 8-K | d150727d8k.htm |
| 2026-05-04 | S-8 | d151302ds8.htm |
| 2026-05-01 | PRE 14A | d59776dpre14a.htm |
| 2026-04-30 | 8-K | d132063d8k.htm |
| 2026-03-26 | 10-K | dbvt-20251231.htm |
| 2026-03-02 | 8-K | d110966d8k.htm |
| 2026-01-20 | 8-K | d74681d8k.htm |
| 2025-12-16 | 8-K | d28682d8k.htm |
| 2025-10-30 | 8-K | d82861d8k.htm |
| 2025-10-29 | 8-K | d53703d8k.htm |